--- title: "ACM Research | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 231.26 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/285540677.md" datetime: "2026-05-07T11:28:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285540677.md) - [en](https://longbridge.com/en/news/285540677.md) - [zh-HK](https://longbridge.com/zh-HK/news/285540677.md) --- # ACM Research | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 231.26 M Revenue: As of FY2026 Q1, the actual value is USD 231.26 M, beating the estimate of USD 215.69 M. EPS: As of FY2026 Q1, the actual value is USD 0.24. EBIT: As of FY2026 Q1, the actual value is USD 33.39 M. #### Segment Revenue - Revenue from single wafer cleaning, Tahoe, and semi-critical cleaning equipment was $122,482 thousand in Q1 2026, compared to $129,569 thousand in Q1 2025. - ECP (front-end and packaging), furnace, and other technologies generated $84,239 thousand in Q1 2026, an increase from $27,630 thousand in Q1 2025. - Advanced packaging (excluding ECP), services, and spares revenue reached $24,542 thousand in Q1 2026, up from $15,148 thousand in Q1 2025. #### Gross Margin GAAP gross margin for ACM Research, Inc. was 46.4% in Q1 2026, a decrease from 47.9% in Q1 2025. Non-GAAP gross margin was 46.5% in Q1 2026, compared to 48.2% in Q1 2025. Both gross margins were above the mid-point of ACM Research, Inc.’s long-term business model target range of 42% to 48%. #### Operating Expenses Total GAAP operating expenses were $71.1 million in Q1 2026, marking a 25.2% increase year-over-year. As a percentage of revenue, GAAP operating expenses decreased to 30.7% from 32.9%. Non-GAAP operating expenses were $65.8 million, up 38.5% year-over-year, and as a percentage of revenue, they increased to 28.4% from 27.6%. #### Operating Income GAAP income from operations for ACM Research, Inc. was $36.2 million in Q1 2026, representing a 40.3% increase compared to $25.8 million in Q1 2025. The GAAP operating margin was 15.6% in Q1 2026, up from 15.0% in Q1 2025. Non-GAAP operating income was $41.8 million, an increase of 17.4% year-over-year compared to $35.6 million, with a non-GAAP operating margin of 18.1% in Q1 2026, compared to 20.7% in Q1 2025. #### Net Income Attributable to ACM Research, Inc. GAAP net income attributable to ACM Research, Inc. was $17.3 million in Q1 2026, compared to $20.4 million in Q1 2025. Non-GAAP net income attributable to ACM Research, Inc. was $24.3 million in Q1 2026, compared to $31.3 million in Q1 2025. #### Cash and Cash Equivalents Cash and cash equivalents, plus restricted cash and short-term time deposits, totaled $1.25 billion at March 31, 2026, an increase from $1.13 billion at December 31, 2025. Net cash, excluding short-term and long-term borrowings, was $924.2 million at March 31, 2026, compared to $844.5 million at December 31, 2025. #### Other Key Financials Total shipments in the first quarter of 2026 were $240.7 million, up 53.6% from $156.7 million in the first quarter of 2025. Unrealized loss on short-term investments was -$1.4 million in Q1 2026, compared to -$1.1 million in Q1 2025. Income tax expense was -$3.8 million in Q1 2026, compared to -$2.2 million in Q1 2025. ACM Research, Inc. completed the sale of approximately 4.8 million shares of ACM Research (Shanghai), Inc., generating approximately $110 million in gross proceeds and $86 million net of taxes. #### Outlook ACM Research, Inc. is maintaining its revenue guidance range of $1.08 billion to $1.175 billion for fiscal year 2026. This outlook is supported by new product cycles, market share gains, and increasing engagement from global customers. The company expects incremental revenue contribution from Tahoe, single-wafer SPM, and vertical furnace, alongside increased evaluations in other platforms. ### Related Stocks - [ACMR.US](https://longbridge.com/en/quote/ACMR.US.md) ## Related News & Research - [Range Impact GAAP EPS of -$0.02, revenue of $0.92M](https://longbridge.com/en/news/286725496.md) - [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md) - [Calidi Biotherapeutics GAAP EPS of -$0.43](https://longbridge.com/en/news/286474175.md) - [China Natural Resources GAAP EPS of -$0.14](https://longbridge.com/en/news/286620443.md)